(−)-L-threo-PDMP (hydrochloride) – 1 mg

Brand:
Cayman
CAS:
161491-04-9
Storage:
-20
UN-No:
Non-Hazardous - /

(–)-L-threo-PDMP is a ceramide analog and one of the four possible stereoisomers of PDMP (Item No. 62595).{11341} L-threo-PDMP is an enhancer of ganglioside biosynthesis.{11341,40478} It increases glucosylceramide synthase activity by 4 and 8% when used at concentrations of 5 and 2.5 µM, respectively, in an enzyme assay.{11341} L-threo-PDMP increases the activity of ganglioside GM3, GD3, and GQ1b synthases and increases the levels of glucosylceramide, lactosylceramide, and ganglioside GM3 in B16 melanoma cells.{40478,40479} It inhibits the growth of MCF-7, MDA-MB-468, SK-BR-3 cells with IC50 values of 4, 7, and 6 µM, respectively.{37415} L-threo-PDMP increases neurite outgrowth and synapse formation in vitro and improves retention of a long-term memory learned prior to forebrain ischemia in rats when administered following ischemia at a dose of 40 mg/kg per day.{40478} The L-threo-PDMP isomer is the glucosylceramide synthetase stimulatory component of DL-threo-PDMP (Item No. 10005276), while D-threo-PDMP (Item No. 10178) is the inhibitory component.{11341}  

 

Available on backorder

SKU: 10005278 - 1 mg Category:

Description

An enhancer of sphingolipid biosynthesis; increases glucosylceramide synthase activity by 4 and 8% when used at concentrations of 5 and 2.5 µM, respectively, in an enzyme assay; increases the activity of ganglioside GM3, GD3, and GQ1b synthases and increases the levels of glucosylceramide, lactosylceramide, and ganglioside GM3 in B16 melanoma cells; inhibits the growth of MCF-7, MDA-MB-468, SK-BR-3 cells (IC50s = 4, 7, and 6 µM, respectively); increases neurite outgrowth and synapse formation in vitro and improves retention of a long-term memory learned prior to forebrain ischemia in rats when administered following ischemia at 40 mg/kg per day


Formal name: N-[(1S,2S)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-decanamide, monohydrochloride

Synonyms: 

Molecular weight: 427

CAS: 161491-04-9

Purity: ≥98%

Formulation: A solid


Product Type|Biochemicals|Small Molecule Activators||Research Area|Cancer||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders||Research Area|Neuroscience|Neuroprotection